← FDA Drug Approvals (Drugs@FDA)

EXKIVITY

NDA · New Drug Application · Sponsor: TAKEDA PHARMS USA · Approved 2021-09-15

Drug application

FDA Application #

NDA215310

Application type

New Drug Application

Brand name

EXKIVITY

Generic name

Mobocertinib Succinate

Active ingredients

MOBOCERTINIB SUCCINATE

Dosage form

CAPSULE

Route

ORAL

Marketing status

Discontinued

Sponsor

TAKEDA PHARMS USA

First approval

2021-09-15

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown